您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > (S)-CR8
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
(S)-CR8
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
(S)-CR8图片
规格:98%
分子量:431.5
包装与价格:
包装价格(元)
1mg电议
5mg电议
10mg电议
25mg电议

产品介绍
(S)-CR8 是 CR8 的 S-异构体。 (S)-CR8 是一种有效的选择性 CDK 抑制剂,对 CDK2/cyclin E、CDK2/cyclin A、CDK9/cyclin T、CDK5/p25 和 CDK1/cyclin 的 IC50 分别为 0.060、0.080、0.11、0.12 和 0.15 μM B,分别。 (S)-CR8 降低 SH-SY5Y 细胞的存活率 (IC50 0.40 μM)。
货号:ajcx20960
CAS:1084893-56-0
分子式:C24H29N7O
分子量:431.5
溶解度:DMSO: soluble,Ethanol: soluble
纯度:98%
存储:Store at -20°C
库存:现货

Background:

(S)-CR8 is a second generation derivative of (R)-roscovitine and an inhibitor of cyclin-dependent kinase 1 (Cdk1/cyclin B), Cdk2/cyclin A, Cdk2/cyclin E, Cdk5/p25, and Cdk9/cyclin T (IC50s = 0.15, 0.08, 0.06, 0.12, and 0.11 µM, respectively).1It also inhibits casein kinase CK1δ/ε (CKδ/ε) and DYRK1A (IC50s = 0.61 and 0.9 µM, respectively). (S)-CR8 reduces cell viability in human neuroblastoma cell lines, including SH-SY5Y, SK-N-AS, SK-N-BE, and IMR32 cells (IC50s = 0.43, 1.46, 0.13, and 0.14 µM, respectively).2It also reduces protein levels of the survival factor Mcl-1 in SH-SY5Y cells.


1.Bettayeb, K., Oumata, N., Echalier, A., et al.CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinasesOncogene27(44)5797-5807(2008) 2.Bettayeb, K., Baunbaek, D., Delehouze, C., et al.CDK inhibitors roscovitine and CR8 trigger Mcl-I down-regulation and apoptotic cell death in neuroblastoma cellsGenes Cancer1(4)369-380(2010)